Re: Participation in experimental treatments

From: J (auteur_at_anon.invalid)
Date: 03/03/05 

Date: Thu, 03 Mar 2005 04:02:17 -0500

eveline wrote:

> participation in cancer trials offers benefits.

Here's another benefit.
http://www.businessweek.com/ap/financialnews/D88HMV4G0.htm
Oncolytics gets FDA OK for Reolysin trial

FEB. 28 2:22 P.M. ET Oncolytics Biotech Inc. said Monday that regulators cleared
the company to begin a clinical trial of its Reolysin cancer treatment in
patients with recurrent brain tumors.

Shares of the Calgary, Alberta-based company rose 21 cents, or 4.6 percent, to
$4.78 in afternoon trading on the Nasdaq.

The biotechnology company said the Phase I/Phase II trial will study the safety
of a single dose of Reolysin administered intravenously in up to 30 patients who
have not responded to traditional treatments. Up to 14 patients will be added
when a maximum tolerated dose is determined.

Quantcast